Home › Cases › Polymorphic VT and Long QT Syndrome
Broad Complex Tachycardia
Polymorphic VT and Long QT Syndrome
6 questions
Question 1 · QT prolongation causes
Correct answer: Drug-induced long QT → risk of torsades de pointes → VF and sudden death
Why
Drug-induced long QT: QTc >500ms significantly increases torsades de pointes risk.
- Macrolides (clarithromycin, azithromycin)
- Fluoroquinolones (ciprofloxacin)
- Antipsychotics (haloperidol, quetiapine)
- Antidepressants (TCAs), methadone, amiodarone, antihistamines (terfenadine)
Clarithromycin: significant QT risk — avoid in baseline long QT or with other QT-prolonging drugs.
Key point
Drug-induced long QT: QTc >500ms → torsades risk. Macrolides, quinolones, antipsychotics, TCAs, methadone.
Question 2 · Managing drug-induced long QT
Correct answer: Stop clarithromycin. Check electrolytes (K+, Mg2+) and replace. Monitor on cardiac telemetry. Switch to alternative antibiotic
Why
Long QT management:
- Stop offending drug
- Correct hypokalaemia and hypomagnesaemia (both prolong QT and trigger torsades)
- Cardiac monitoring/telemetry
- Avoid all other QT-prolonging drugs
- If QTc >500ms: consider admission, telemetry
- If torsades develops: IV magnesium 2g, temporary pacing (overdrive pacing reduces QT)
Key point
Drug-induced long QT: stop drug, correct K+ and Mg2+, telemetry, avoid all other QT-prolonging drugs.
Question 3 · Congenital long QT
Correct answer: Congenital long QT syndrome — autosomal dominant, exertional or emotion-triggered syncope/VF, family history of sudden death
Why
Congenital LQTS: inherited channelopathies (most common: LQT1 — exertion/swimming, LQT2 — auditory stimuli, LQT3 — sleep). Family history of sudden cardiac death in young relatives, syncope during exercise/emotion. 12-lead ECG during and after exercise. Genetic testing. High risk of VF.
Key point
Congenital LQTS: young patient, exertional syncope, family history of sudden death. Exercise ECG. Genetic testing.
Question 4 · LQTS treatment
Correct answer: Beta-blocker (nadolol or propranolol) — first line for LQT1 and LQT2. ICD if high risk (prior cardiac arrest, QTc >500, symptomatic despite beta-blockers)
Why
LQTS treatment: Beta-blockers first line (nadolol preferred — non-selective, longer-acting). Particularly effective in LQT1 (exercise-triggered). Avoid QT-prolonging drugs. ICD if: prior cardiac arrest, symptomatic despite beta-blockers, QTc >550ms. Left cardiac sympathetic denervation (LCSD) for high-risk patients declining ICD.
Key point
LQTS: beta-blocker (nadolol) first line. ICD for high risk. Avoid QT drugs. Avoid competitive sports in LQT1.
Question 5 · Brugada syndrome
Correct answer: Brugada syndrome — coved-type ST elevation V1-V2, RBBB pattern, syncope/VF at rest/sleep
Why
Brugada syndrome: sodium channelopathy (SCN5A). ECG: coved-type ST elevation V1-V2 (type 1 pattern). Arrhythmias occur at rest or during sleep (unlike LQT1 which is exertional). Fever can trigger arrhythmias. Male predominance. Common in Southeast Asian populations. Treatment: ICD (only effective treatment).
Key point
Brugada: coved ST elevation V1-V2, rest/sleep syncope, male predominance. ICD is the only effective treatment.
Question 6 · Sudden cardiac death screening
Correct answer: Yes — first-degree relatives of LQTS patients should be screened with 12-lead ECG, exercise test, and genetic testing
Why
Inherited arrhythmia family screening: first-degree relatives of LQTS, Brugada, HCM, ARVC should all be screened. ECG, exercise test, echocardiogram as appropriate. Genetic testing if index case mutation identified. Cardiology specialist centre (inherited cardiac conditions clinic). Beta-blockers even for genotype-positive asymptomatic LQT1.
Key point
Inherited arrhythmia: screen all first-degree relatives. ECG + exercise test + genetic testing. Even asymptomatic family.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.